Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy
References
- [1] Amman, R. W., Eckert, J. (1996): Echinococcus. In Weinstock, J. V. (Ed): Parasitic diseases of the liver and intestines. Saunders, Philadelphia, pp 655–689
- [2] Amman, R. W., Ilitsch, A., Marincek, B., Freiburghaus, A. U. (1994): Effect of chemotherapy on the larval mass and the long — term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Hepatology, 19: 735–742
- [3] Bresson-Hadni, S., Vuitton, D. A., Bartholomot, B., Godart, D., Meyer, J. P., Hrusovsky, S., Becker, M. C., Miguet, J. P. (2000): A 20-year history of alveolar echinococcosis in humans. Analysis of a series of 117 patients from eastern France. Eur. J. Gastroenterol. Hepatol., 12: 327–336
- [4] Craig, P. (2003): Echinococcus multilocularis. Curr. Opin. Infect. Dis., 16: 437–444 http://dx.doi.org/10.1097/00001432-200310000-00010
- [5] Dayan, A. D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica., 86: 141–159 http://dx.doi.org/10.1016/S0001-706X(03)00031-7
- [6] Didier, D., Weiler, S., Rohmer, P., Lassegue, A., Deschamps, J.-P., Vuitton, D., Miguet, J. P., Weill, F. (1985): Hepatic alveolar echinococcosis: Correlative US and CT study. Radiology, 154: 179–186
- [7] Eckert, J., Amman, R. W. (1995): Clinical diagnosis and treatment of echinococcosis in human. In Thompson, R. C. A., Lymbery, A. J., (Eds): Echinococcus and hydatid disease. Wallingford: CAB International, pp 411–463
- [8] Eckert, J., Deplazes, P. (1999): Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol. Today, 15: 315–319 http://dx.doi.org/10.1016/S0169-4758(99)01476-3
- [9] Eckert, J., Gottstein, B., Heath, D., Liu, F. J. (2001): Prevention of echinococcosis in humans and safety precations. In Eckert, J., Gemmel, M. A., Meslin, F. X., Pawlowski, Z. S. (Eds): WHO/OIE Manual on Echinococcosis in humans and animals: a public health problem of global concern. Paris: WHO and OIE, pp 238–247
- [10] Giraudoux, P., Raoul, F., Bardonnet, K., Vuillaume, P., Tourneux, F., Cliquet, F., Dellatre, R., Vuitton, D.-A. (2001): Alveolar echinococcosis: characteristics of a possible emergence and new perspectives in epidemiosurveillance. Méd. Mal. Infect., 31: 247–256 http://dx.doi.org/10.1016/S0399-077X(01)80065-2
- [11] Gottstein, B., Tschudi, K., Eckert, J., Ammann, R. (1989): Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans. Royal Soc. Trop. Med. Hyg., 83: 389–393 http://dx.doi.org/10.1016/0035-9203(89)90512-9
- [12] Hattingen, J., Uerlings, A., Jaussi, R. (1996): Alveoläre Echinokokkose der Leber mit Lymfogener pulmonaler und zerebraler Metastasierung. Forschr Rontgenstr, 1: 91–94 http://dx.doi.org/10.1055/s-2007-1015721
- [13] Ishizu, H., Uchino, J., Sato, N., Aoki, S., Suzuki, K., Kuribayashi, H. (1997): Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology, 25: 528–531 http://dx.doi.org/10.1002/hep.510250305
- [14] Ito, A., Schantz, P. M., Wilson, J. F. (1995): Em18, a new serodiagnostic marker for differentiation of active and inactive cases in alveolar hydatid disease. A. J. Trop. Med. Hyg., 52: 41–44
- [15] Kern, P., Bardonnet, K., Renner, E., Auer, H., Pawlowski, Z., Amman, R. W., Vuiton, D. A., Kern, P. (2003): European Echinococcosis Registry: human alveolar echinococcosis, Europe. 1982–2000. Emer. Inf. Dis., 9: 343–349
- [16] Kinčeková, J., Auer, H., Reiterová, K., Dubinský, P., Szilágyiová, M., Lauko, L’, Aspöck, H. (2001): The first case of autochthonous human alveolar echinococcosis in the Slovak Republic. Mitt. Österr. Ges. Tropenmed. Parasitol., 23: 33–38
- [17] Kinčeková, J., Reiterová, K., Dubinský, P., Szilágyiová, M., Johanes, R., Gottas, M. (2002): A second case of autochthonous human alveolar echinococcosis in the Slovak Republic. Helminthologia, 39: 193–196
- [18] Lucius, R., Bilger, B. (1995): Echinococcus multilocularis in Germany: Increased awarenes or spreading of a parasite? Parasitol. Today, 11: 430–434 http://dx.doi.org/10.1016/0169-4758(95)80030-1
- [19] Matossian, R. M., Awar, G. N., Radwan, H., Craig, P. S., Meshefedjian, G. A. (1992): Immune status during albendazole therapy for hydatidosis. Annals Trop. Med. Parasitol., 86: 67–75
- [20] Miguet, J. P., Monange, C., Carbillet, J. P. (1976): L’échinococcose alvéolaire du foie. A propos de 20 cas observés en Franche-Comté. Etude anatomo-pathologique. Arch. Fr. Mal. Appl. Dig., 65: 23–32
- [21] Rawden, H. C., Kokwaro, G. O., Ward, S. A., Edwards, G. (2000): Relative contribution of cytochromes P450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br. J. Clin. Pharmamacol., 49: 313–322 http://dx.doi.org/10.1046/j.1365-2125.2000.00170.x
- [22] Reuter, S., Jensen, B., Buttenschoen, K., Kratzer, W., Kern, P. (2000): Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother., 46: 451–456 http://dx.doi.org/10.1093/jac/46.3.451
- [23] Reuter, S., Nussle, K., Kolokythas, O., Hang, U., Rieber, A., Kern, P., Kratzer, W. (2001): Alveolar liver echinococcosis: A comparative study of three imaging techniques. Infection, 29: 119–125 http://dx.doi.org/10.1007/s15010-001-1081-2
- [24] Reuter, S., Schirrmeister, H., Kratzer, W., Dreweck, C., Reske, S. N., Kern, P. (1999): Pericystic metabolic activity in alveolar echinococcosis: Assessment and follow-up by positron emission tomography. Clin. Inf. Dis., 29: 1157–1163 http://dx.doi.org/10.1086/313438
- [25] Rigano, R., Profumo, E., Ioppolo, S., Notargiacomo, S., Ortona, E., Teggi, A., Siracusano, A. (1995): Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin. Exp. Immunol., 102: 281–285 http://dx.doi.org/10.1111/j.1365-2249.1995.tb03778.x
- [26] Short, J. A., Heiner, D. C., Hsiao, R. L., Andersen, F. L. (1990): Immunoglobulin E and G4 antibodies in cysticercosis. J. Clin. Microbiol., 28: 1635–1639
- [27] Stanley, R. J. (1983): Liver and biliary tract. In Lee, J. K. T., Sagel, S. S., Stanley, R. J. (Eds): Computed Body Tomography. New York, Raven Press, pp 167–211
- [28] Šlais, J., Madle, A., Vanka, K., Jelínek, F., Černik, M., Průchova, M., Jindra, J. (1979): Alveolar hydatidosis (echinococcosis) diagnosis by liver puncture biopsy. Čas. lék. čes., 15: 472–476
- [29] Wen, H., Bresson-Hadni, S., Vuiton, D. A., Lenys, D., Yang, B. M., Ding, Z. X., Craig, P. S. (1995): Analysis of immunoglobulin G subclass in the serum antibody response of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans. Royal Soc. Trop. Med. Hyg., 89: 692–697 http://dx.doi.org/10.1016/0035-9203(95)90449-2
- [30] Wen, H., Craig, P. S. (1994): Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. Annals Trop. Med. Hyg., 51: 741–748
- [31] World Health Organisation (1996): Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bulletin of the World Health Organisation, 74: 231–242
Language: English
Page range: 213 - 219
Published on: Dec 1, 2006
Published by: Slovak Academy of Sciences, Institute of Parasitology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
Related subjects:
© 2006 J. Kinčeková, G. Hrčková, H. Auer, M. Szilágyiová, J. Hudačková, M. Stanislayová, H. Poláček, K. Šimeková, published by Slovak Academy of Sciences, Institute of Parasitology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.